Dyne Submits DMD Treatment Application
Dyne submits biologics license application for Duchenne muscular dystrophy treatment, seeking regulatory approval. This could impact the biotech sector.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.